Searle Company Ltd · PSX:SEARL
Searle — The Searle Company — Investor Presentation (2020)
22 slides from Searle's investor presentation, 2020
Slide 1: Corporate Briefing Session: The Searle Company
CORPORATE BRIEFING SESSION The Searle Company TO LEAD IN IMPROVING THE QUALITY OF HUMAN LIFE
Slide 2: Brief history of IBL
Brief history of IBL PA R T N E R S H I P, I N T E G R I T Y, PA S S I O N & E X C E L L E N C E • The Group began its operations several generations ago with the inception of a distribution house. In 1887 it became distributors for W.D. & H.O. Wills cigarettes for all the pre-partition Indian sub-c
Slide 3: IBL Business Operations
IBL Business Operations O U R FA M I LY A N D T H E I R A F F I L I AT E S IBL 3
Slide 4: Brief history of Searle
Brief history of Searle PA R T N E R S H I P, I N T E G R I T Y, PA S S I O N & E X C E L L E N C E • Originally founded in US in 1888 by Gideon D. Searle. • Incorporated in Pakistan as a Private Limited Company in 1965 as a subsidiary of G.D. Searle & Co., USA. 4
Slide 5: Our Footprint
Our Footprint TOUCHING LIFE OF MILLIONS BY BRINGING E XCE LLENCE IN C O M M E R C I A L O P E R AT I O N S ND No. 1 2 1Billion Plus Billion Rupee Club i. ii. iii. Cardiovascular Pain Management Gynae and Obs Largest Pharmaceutical Company In terms of Product Consumptions(Unit) 4 Brands iv. Cough Sup
Slide 6: Our Promise
Our Promise Searle was ranked as the most COMMITMENT TO EXCELLENCE 01 outstanding company in Pakistan as per Asiamoney’s Outstanding Companies Poll, 2018. As per MSCI, Searle was top ranked listed entity of Pakistan with the highest performance growth of 52% in share prices. 02 Searle since 2018, ha
Slide 7: Our Product Portfolio
Our Product Portfolio M A R K E T I N G A U T H O R I Z AT I O N 15 470 Biotech Local Registration Registration 288 25 Global Enlistments Registration 18 6 Medical Drug Device Manufacturing Registration License
Slide 8: Our Brands
Our Brands LEADING BRANDS IN THEIR THERAPEUTIC AREA Cough • Hydryllin Iron Plain • Venofer, Ferinject Muscle • Nuberol Relaxant Antibiotics • Tainem, Invanz ORS • Peditral Corticosteroid • Decaderon • Extor, Spiromide, Cardiovascular Byscard Nitrites & • Sustec Analgesic • Tramal, Rotec Nitrates • G
Slide 9: Our Partners
Our Partners T R U S T O F O U R A F F I L I AT O R S 9
Slide 10: Our Presence
Our Presence OUR BOND WITH THE GLOBAL VILLAGE Afghanistan Oman Myanmar Guatemala Sudan Laos Senegal Nigeria Yemen Vietnam Ethiopia Cambodia Ivory Coast Uganda Sri Lanka Kenya Philippines Ghana Cameroon Rwanda Tanzania Maldives Mauritius Existing Market - 15 Future Market - 7
Slide 11: Our Facilities
Our Facilities S TAT E - O F - T H E - A R T FA C I L I T I E S • Karachi Plant 1 (GD Searle) Searle Company • Karachi Plant 2 (MSD) Limited • Lahore Plant 1; Lahore Plant 2 Searle Biosciences • Nextar Plant Port Qasim 6 Manufacturing Facilities Producing >250Million Units Annually Searle Laboratori
Slide 12: Our R&D Center
Our R&D CENTER I N T E R N AT I O N A L C E N T E R F O R C H E M I C A L A N D B I O L O G I C A L SCIENCES (ICCBS), UNIVERSITY OF KARACHI TSCL has established a state-of- the-art Research & Development Centre at ICCBS Technology Park with first of its kind technology incubator in Pakistan.
Slide 13: Industry Rankings
Industry Rankings SEARLE IS RANKED NUMBER 2ND IN TERMS OF VOLUME AND RANKEND 4TH IN TERMS OF VALUE 2020 – VOLUME IMS MAT SEPTEMBER Market Share Growth % 2020 – VALUE IMS MAT SEPTEMBER Market Share Growth % GSK 340,499,281 11.52% -4.23% GSK 33,435,849,263 6.88% 7.20% Searle 208,042,622 7.04% 17.95% G
Slide 14: Our Volume
Our Volume SEARLE JUMPED FROM BEING AT NUMBER 8TH IN 2008 TO NUMBER 2ND IN 2020 IN THE IMS RANKING WITH REFERENCE TO REVENUE IN TERMS OF UNITS SOLD Rank Searle has a large and Value in Thousands 2020 208,042 2nd sustainable customer base 2019 198,157 2nd because of more focus on 2018 176,602 3rd the
Slide 15: Our Position
Our Position SEARLE JUMPED FROM BEING AT NUMBER 11TH IN 2008 TO NUMBER 4TH IN 2020 IN THE IMS RANKING WITH REFERENCE TO REVENUE IN TERMS OF VALUE Rank 2020 28,084 4th Value in Millions 2019 26,776 4th 2018 22,843 5th 2017 17,163 6th 2016 12,811 5th 2015 11,790 6th 2014 9,809 7th 2013 8,078 8th 2012
Slide 16: Our Revenue
Our Revenue T H E R E V E N U E I N S E A R L E I N C R E A S E D R A P I D LY D U R I N G T H E LAST 20 YEARS The revenue of the company grown from 2.7 billion in 2008 to 20.4 billion 20.4 in 2020, representing an average growth rate of 18.31% per annum billion Management change 2.7 billion 1.3 bil
Slide 17: Our Profits
Our Profits THE PROFIT WHICH SEARLE USED TO MAKE IN 2007 NOW R E P R E S E N T S O N LY N I N E D AY S O F P R O F I T The profits increased sharply during the last 13 2.54 years from just 64 million in 2007 to 2.54 billion in billion the year 2020, representing an average growth rate of 32.84%. The
Slide 18: Our Strategy
Our Strategy N E W V S . E X I S T I N G P R O D U C T P E R C E N TA G E Old New 47% 46% 46% 43% 41% 40% New products within top 10 Rapid increase in share of top 10 products: 46% 44% 39% 54% 56% 61% - 2013 - 46% - 2015 - 56% - 2017 - 61% 59% 60% 57% 53% 54% 54% 2015 2016 2017 2018 2019 2020 18
Slide 19: Financial Information
Financial Information 2020 2019 2018 Revenue 16,567,219 14,537,198 12,675,110 PFO % 23.82% 22.41% 27.13% Standalone Financials PAT % 14.82% 18.17% 24.06% EPS 11.56 12.44 14.35 Cash Dividend 25.00% 25.00% 50.00% Bonus Dividend 0.00% 0.00% 15.00% 2020 2019 2018 Revenue 20,474,842 18,062,107 16,148,468
Slide 20: Our Future
Our Future B L A Z I N G TO WA R D S A R A D I A N T F U T U R E 01 Will be the number 1 pharmaceutical company in Pakistan 02 Will have global presence in more than 50 countries Will have the largest field force of 03 highly trained medical representatives 04 Will have FDA approved manufacturing fa
Slide 21: Corporate Social Responsibility
Corporate Social Responsibility RESEARCH IN THE SERVICE OF MANKIND • Searle is committed towards saving environment and creating a sustainable clean future. Searle plans to plant 300 thousands trees in various parks around the city of Karachi. • Searle won the National Forum for Environment and Heal
Slide 22: Our Commitment to Society
Our Commitment to Society RESEARCH IN THE SERVICE OF MANKIND 22